12:12 PM
 | 
Feb 09, 2018
 |  BC Week In Review  |  Company News  |  Deals

Advanced Proteome, ImmunoBiochem to develop ADCs for TNBC

Advanced Proteome Therapeutics Corp. (TSX-V:APC; FSE:0E8) and ImmunoBiochem Corp. (Toronto, Ontario) will evaluate combining an undisclosed antibody from ImmunoBiochem with Advanced...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >